✦ LIBER ✦

P-12-28 - Safety & tolerability of combined treatment with moclobemide and SSRIs: A preliminary study

✍ Scribed by C.J. Hawley; S. Ratnam; S. Quick; D. Echlin; H. Pattinson

Book ID: 119177585
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 154 KB
Volume: 6
Category: Article
ISSN: 0924-977X
DOI: 10.1016/0924-977x(96)87889-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-28 Comparison of moclobemide and sertr

P-28 Comparison of moclobemide and sertraline in the treatment of atypical depression: A preliminary study

✍ S.D. Örsel; M.H. Türkşapar; E.N.D. Işcan; A. Akdemir; A. Şirin; E. Göka; M.H. Öz 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 290 KB

P1-337 Safety and tolerability of high d

P1-337 Safety and tolerability of high dose donepezil in patients with Alzheimer's disease. A preliminary report of a pilot study

✍ Mark D. Pass; Joshua R. Shua-Haim; Suhas Patel; Sameer Patel; Paul Lee; Pritesh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 152 KB

P.08.17 SAFETY AND TOLERABILITY OF SORAF

P.08.17 SAFETY AND TOLERABILITY OF SORAFENIB TREATMENT FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH SEVERE IMPAIRMENT OF LIVER FUNCTION: A PROSPECTIVE STUDY

✍ A.L. Inghilesi; D. Gallori; L. Antonuzzo; F. Pasquinelli; U. Arena; G. Laffi; F. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

A preliminary open study of the tolerabi

A preliminary open study of the tolerability and effectiveness of nefazodone in major depressive disorder: Comparing patients who recently discontinued an ssri with those on no recent antidepressant treatment

✍ David Mischoulon; Gudrun Opitz; Karen Kelly; Maurizio Fava; Jerrold F. Rosenbaum 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

50 A phase I study of the safety, tolera

50 A phase I study of the safety, tolerability and pharmacokinetics of pazopanib (P) in combination with gemcitabine (G) for advanced solid tumors

✍ H. Richly; S.D. Rubin; A. Madi; M. Jeffels; B. Nokay; D. Gibson; S. Weller; M.E. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Tolerability and safety profile of 12- t

Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 µg QOD in patients with relapsing-remitting multiple sclerosis: A multicenter, randomized, double-blind, parallel-group pilot study

✍ Barrie J. Hurwitz; Douglas Jeffery; Barry Arnason; Kim Bigley; Patricia Coyle; D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 213 KB